In fact, the percentage of CD8+ Eomes+ was significantly increased in PASC patients when compared to HC and to non-PASC patients (p = 0.017 and p = 0.031 for HC and Non-PASC, respectively; Fig. 4B). This evidence concerns the gene CD8A and long COVID-19.